Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Short-term Investments (2010 - 2026)

Incyte's (INCY) quarterly Short-term Investments came in at $553.4 million in Q2 2026, up 18.55% YoY from $466.8 million in Q2 2025, and little changed on a QoQ basis from $554.7 million in Q1 2026.

Analysis

Incyte (INCY) Short-term Investments (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Short-term Investments data on file, last reported at $553.4 million in Q2 2026.

  • Quarterly Short-term Investments rose 18.55% year-over-year to $553.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $553.4 million (up 18.55% YoY) and the FY2025 annual result came in at $482.8 million, up 2.66% from the prior year.
  • Short-term Investments steadied at $553.4 million in Q2 2026, from $554.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $554.7 million in Q1 2026 to a low of $286.5 million in Q3 2022.
  • A 5-year average of $409.3 million and a median of $464.5 million in 2024 frame the typical range for Short-term Investments.
  • Annual changes were most pronounced in 2024 — Short-term Investments soared 72.97% — and 2025, when it fell 7.44%.
  • Tracing INCY's Short-term Investments over 5 years: stood at $287.5 million in 2022, then soared by 53.95% to $442.7 million in 2023, then gained by 6.23% to $470.3 million in 2024, then climbed by 2.66% to $482.8 million in 2025, then gained by 14.62% to $553.4 million in 2026.
  • The last three Short-term Investments figures came in at $553.4 million (Q2 2026), $554.7 million (Q1 2026), and $482.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 553.37 Mn
Mar 31, 2026 554.71 Mn
Dec 31, 2025 482.79 Mn
Sep 30, 2025 474.81 Mn
Jun 30, 2025 466.77 Mn
Mar 31, 2025 466.94 Mn
Dec 31, 2024 470.26 Mn
Sep 30, 2024 467.24 Mn
Jun 30, 2024 462.21 Mn
Mar 31, 2024 504.48 Mn
Dec 31, 2023 442.67 Mn
Sep 30, 2023 289.22 Mn
Jun 30, 2023 292.24 Mn
Mar 31, 2023 291.66 Mn
Dec 31, 2022 287.54 Mn
Sep 30, 2022 286.50 Mn
Jun 30, 2022 287.04 Mn
Mar 31, 2022 287.40 Mn
Dec 31, 2021 290.75 Mn
Sep 30, 2021 285.05 Mn